Diagnostic value of the fluoroscopic triggering 3D LAVA technique for primary liver cancer

Hepatobiliary and Pancreatic Diseases International

Volumn 9, Issue 2, 2010, Pages 159-163

  Shen, Xiao Yong ^a   Chai, Chun Hua ^a   Xiao, Wen Bo ^a   Wang, Qi Dong ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Diagnosis; Imaging; LAVA sequence; Liver neoplasm

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; FLUOROSCOPY; HUMAN; IMAGE QUALITY; LIVER CANCER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; TUMOR BIOPSY;

ADULT; AGED; FEMALE; FLUOROSCOPY; HEPATIC ARTERY; HUMANS; IMAGING, THREE-DIMENSIONAL; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PORTAL VEIN;

EID: 77951862346     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Tsim NC, Frampton AE, Habib NA, Jiao LR. Surgical treatment for liver cancer. World J Gastroenterol 2010;16:927-933.
2. Voroney JP, Brock KK, Eccles C, Haider M, Dawson LA. Prospective comparison of computed tomography and magnetic resonance imaging for liver cancer delineation using deformable image registration. Int J Radiat Oncol Biol Phys 2006;66:780-791. (Pubitemid 44436695)
3. Zhou XP, Yang GS, Lu JH, Zhang HB, Li QG, Han LZ, et al. Prospective study of liver parenchyma volume in hepatectomy of primary liver cancer. Zhonghua Wai Ke Za Zhi 2005;43: 1370-1374.
4. Kirchner J, Kickuth R, Laufer U, Noack M, Liermann D. Optimized enhancement in helical CT: experiences with a realtime bolus tracking system in 628 patients. Clin Radiol 2000; 55:368-373. (Pubitemid 32054496)
5. Lee CH, Goo JM, Lee HJ, Kim KG, Im JG, Bae KT, et al. Determination of optimal timing window for pulmonary artery MDCT angiography. AJR Am J Roentgenol 2007;188:313317.
6. Danias PG, McConnell MV, Khasgiwala VC, Chuang ML, Edelman RR, Manning WJ. Prospective navigator correction of image position for coronary MR angiography. Radiology 1997;203:733-736. (Pubitemid 27227422)
7. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108. (Pubitemid 29094960)
8. Zhang M, Li B, Yan LN, Yin F, Wen TF, Zeng Y, et al. Development of a survival evaluation model for liver transplant recipients with hepatocellular carcinoma secondary to hepatitis B. World J Gastroenterol 2008;14:1280-1285. (Pubitemid 351356340)
9. Sun Z, Ming L, Zhu X, Lu J. Prevention and control of hepatitis B in China. J Med Virol 2002;67:447-450.
10. Bouza C, López-Cuadrado T, Alcázar R, Saz-Parkinson Z, Amate JM. Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma. BMC Gastroenterol 2009;9:31.
11. Huang ZQ. Advance and development of clinical diagnosis of obstructive. Chin J Pract Surg 2001;21:449.
12. Nonami T, Harada A, Kurokawa T, Nakao A, Takagi H. Advances in hepatic resection and results for hepatocellular carcinoma. Semin Surg Oncol 1996;12:183-188. (Pubitemid 26154624)
13. Burke D, Earlam S, Fordy C, Allen-Mersh TG. Effect of aberrant hepatic arterial anatomy on tumour response to hepatic artery infusion of floxuridine for colorectal liver metastases. Br J Surg 1995;82:1098-1100.
14. Yang GS, Wu ZQ, Wu MC. Comprehensive treatment for primary liver cancer. Hepatobiliary Pancreat Dis Int 2003;2:2327.
15. Dugdale PE, Miles KA, Bunce I, Kelley BB, Leggett DA. CT measurement of perfusion and permeability within lymphoma masses and its ability to assess grade, activity, and chemotherapeutic response. J Comput Assist Tomogr 1999;23: 540-547. (Pubitemid 29337146)
16. Brix G, Bahner ML, Hoffmann U, Horvath A, Schreiber W. Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CT-initial experience. Radiology 1999;210:269-276. (Pubitemid 29004315)
17. Hawighorst H, Schoenberg SO, Knopp MV, Essig M, Miltner P, van Kaick G. Hepatic lesions: morphologic and functional characterization with multiphase breath-hold 3D gadoliniumenhanced MR angiography-initial results. Radiology 1999;210: 89-96. (Pubitemid 29004288)
18. Grazioli L, Morana G, Kirchin MA, Schneider G. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 2005;236:166-177. (Pubitemid 40853309)
19. Shimada K, Isoda H, Okada T, Kamae T, Arizono S, Hirokawa Y, et al. Unenhanced MR portography with a half-Fourier fast spin-echo sequence and time-space labeling inversion pulses: preliminary results. AJR Am J Roentgenol 2009;193:106-112.
20. Bian J, Sha L, Yang C, Sun CS. Three-dimensional dynamic contrast-enhanced MR angiography for evaluating recipient vessels in orthotopic liver transplantation. Hepatobiliary Pancreat Dis Int 2008;7:476-480.
21. Pandharipande PV, Krinsky GA, Rusinek H, Lee VS. Perfusion imaging of the liver: current challenges and future goals. Radiology 2005;234:661-673. (Pubitemid 40250807)
22. Tajima T, Honda H, Taguchi K, Asayama Y, Kuroiwa T, Yoshimitsu K, et al. Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation. AJR Am J Roentgenol 2002;178:885-897. (Pubitemid 34250225)
23. Miles KA, Griffiths MR. Perfusion CT: a worthwhile enhancement? Br J Radiol 2003;76:220-231.
24. Thorgeirsson SS, Lee JS, Grisham JW. Molecular prognostication of liver cancer: end of the beginning. J Hepatol 2006;44: 798-805.
25. Sidransky D. Emerging molecular markers of cancer. Nat Rev Cancer 2002;2:210-219. (Pubitemid 37328790)
26. Holland AE, Hecht EM, Hahn WY, Kim DC, Babb JS, Lee VS, et al. Importance of small (< or=20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology 2005;237:938-944.
27. Efremidis SC, Hytiroglou P. The multistep process of hepatocarcinogenesis in cirrhosis with imaging correlation. Eur Radiol 2002;12:753-764. (Pubitemid 36940129)